Search results
Merck Raises Forecast as Sales of Its Cancer Immune Therapy Soar
Bloomberg· 6 days agoMerck & Co. raised its annual profit and revenue forecast as the blockbuster cancer drug Keytruda...
Pfizer’s first-quarter results top estimates, while drugmaker boosts full-year profit outlook
Market Watch· 3 hours agoAn expected drop in COVID-19-related product sales, including antiviral Paxlovid and vaccine...
MRK Stock Sees Surge of Approximately 1.30% in Last Five Days – Knox Daily
Knox Daily· 6 days agoInvestors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Merck & Co Inc shares valued at $492,135,715 ...
Merck raises 2024 profit forecast on strong sales of cancer drug Keytruda
Reuters via AOL· 6 days ago(Reuters) -Merck & Co on Thursday raised its annual profit and revenue forecast on the back of...
Merck’s first-quarter results beat expectations amid healthy vaccine-sales growth
Market Watch· 6 days agoMerck & Co. Inc. on Thursday reported first-quarter results that beat analysts’ expectations amid...
Merck: Q1 Earnings Snapshot
Associated Press Finance via Yahoo Finance· 6 days agoRAHWAY, N.J. (AP) — RAHWAY, N.J. (AP) — Merck & Co. (MRK) on Thursday reported first-quarter earnings of $4.76 billion. On a per-share basis, the Rahway ...
Merck raises 2024 profit forecast on strong sales of cancer drug Keytruda
Reuters via Yahoo Finance· 6 days ago(Reuters) -Merck & Co on Thursday raised its annual profit and revenue forecasts on the back of...
Merck: Q1 Earnings Snapshot
Houston Chronicle· 6 days agoRAHWAY, N.J. (AP) — Merck & Co. (MRK) on Thursday reported first-quarter earnings of $4.76 billion. On a per-share basis, the Rahway, New Jersey-based company ...
Merck (MRK) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 6 days agoWelcome to the Merck & Co. Q1 sales and earnings conference call. [Operator instructions] This call is being recorded. If you have any objections, you...
Merck's first-quarter results beat expectations amid healthy vaccine-sales growth
Morningstar· 6 days agoMerck & Co. Inc. on Thursday reported first-quarter results that beat analysts' expectations amid strong sales of vaccines and cancer drug Keytruda. First-quarter ...
